PFE Total Non-Current Assets

Pfizer · Total Non-Current Assets

PFE logo

PFE Total Non-Current Assets

Latest reported$159.77B
PFE Quarterly Non-Current Assets ($2.30B → $159.77B)
High-resolution chart · PNG

PFE total non-current assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer Total Non-Current Assets — Quarterly (USD)
Period endingTotal Non-Current Assets (USD)
159,773,000,000
164,796,000,000
165,262,000,000
161,807,000,000
162,392,000,000
162,166,000,000
163,038,000,000
176,254,000,000
178,367,000,000
178,680,000,000
183,168,000,000
141,009,000,000
146,821,000,000
145,539,000,000
145,944,000,000
124,946,000,000
127,824,000,000
129,420,000,000
121,782,000,000
121,288,000,000
121,106,000,000
119,284,000,000
119,163,000,000
131,245,000,000
131,511,000,000
131,599,000,000
134,685,000,000
136,987,000,000
109,126,000,000
110,132,000,000
109,497,000,000
126,256,000,000
127,678,000,000
129,777,000,000
130,654,000,000
131,861,000,000
132,174,000,000
132,904,000,000
132,666,000,000
139,927,000,000
126,812,000,000
121,631,000,000
123,658,000,000
125,865,000,000
109,162,000,000
111,196,000,000
111,573,000,000
114,376,000,000
114,325,000,000
114,015,000,000
115,857,000,000
116,021,000,000
117,900,000,000
122,635,000,000
124,383,000,000
125,476,000,000
124,077,000,000
130,820,000,000
130,274,000,000
133,400,000,000
135,415,000,000
136,712,000,000
134,546,000,000
137,326,000,000
139,970,000,000
145,197,000,000
151,279,000,000
67,510,000,000
67,789,000,000
68,679,000,000
68,072,000,000
67,022,000,000
67,864,000,000
67,539,000,000
68,419,000,000
67,190,000,000
68,781,000,000
68,146,000,000
67,888,000,000
69,864,000,000
70,556,000,000
75,544,000,000
75,669,000,000
77,575,000,000
78,754,000,000
80,582,000,000
83,990,000,000
83,172,000,000
83,276,000,000
86,900,000,000
87,034,000,000
86,991,000,000
89,514,000,000
21,825,000,000
21,575,000,000
21,206,000,000
20,182,000,000
20,346,000,000
20,703,000,000
18,807,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.